Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis

Author： Ulanova Marina Duta Florentina Puttagunta Lakshmi Schreiber Alan D Befus A Dean

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.5, 2005-10, pp. : 901-921

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1739-1744

Bentham Science Publishers

Access to resources Recommend Favorite

Montelukast an advantage for asthma and allergic rhinitis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The Syk kinase as a therapeutic target in leukemia and lymphoma

By Efremov Dimitar G Laurenti Luca

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 623-636

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab effective in allergic asthma and allergic rhinitis

Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Tyrosine kinase: novel target in Ewing's sarcoma?

Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite